Concepedia

Janette Sutton

JS

13

Publications

986

Citations

12

H-Index

2008

Active since

Affiliations

Pfizer (United States)(Current)

Allogene Therapeutics (United States)

Cellectis (United States)

Janette Sutton is an author at Pfizer (United States) specializing in medicine, antibody engineering, and immunotherapy.

ORCID

Top concepts

Publications per year

2008–2023

13

Publications

13

Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9

Javier Chaparro‐Riggers, Liang Hong, Rachel M. DeVay et al. · Journal of Biological Chemistry · 2012 · 164 citations · Full text

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma

Cesar Sommer, Bijan Boldajipour, Tracy C. Kuo et al. · Molecular Therapy · 2019 · 156 citations · Full text

Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair

Pavel Strop, Wei-Hsien Ho, Leila M. Boustany et al. · Journal of Molecular Biology · 2012 · 145 citations

, , +12

Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates

Liang Hong, Javier Chaparro‐Riggers, Pavel Strop et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 105 citations

CGRP function‐blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat

James R. Zeller, Kris Poulsen, Janette Sutton et al. · British Journal of Pharmacology · 2008 · 88 citations · Full text

Rows per page

1–5 of 13